Encompass Health (NYSE: EHC) director receives 40 dividend-equivalent RSUs in July award

Q: What triggered the 40 restricted stock units awarded to the Encompass Health (EHC) director?

The 40 RSUs were credited under existing restricted stock unit award agreements in connection with Encompass Health’s common stock dividend. On July 15, 2026, the company paid a $0.19 per-share dividend, which generated these dividend-equivalent units.

Q: Was Nancy M. Schlichting’s Encompass Health (EHC) Form 4 a market purchase or sale?

No market purchase or sale occurred. The Form 4 reports an acquisition by grant/award of 40 restricted stock units. This is a compensation-related, dividend-equivalent award rather than an open-market buy or sell transaction.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Nancy M. Schlichting received an automatic award of 40 restricted stock units tied to Encompass Health common stock on July 15, 2026. The award represents dividend equivalents on existing RSUs, based on a $0.19 per-share dividend and a $109.88 closing price. Following this award, her directly reported holdings total 22,972 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SCHLICHTING NANCY M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	40	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 22,972 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

RSUs Awarded: 40 units Holdings After Transaction: 22,972 shares Dividend Per Share: $0.19 per share +1 more

4 metrics

RSUs Awarded 40 units Restricted stock units credited to Nancy M. Schlichting on July 15, 2026

Holdings After Transaction 22,972 shares Directly reported holdings following the July 15, 2026 award

Dividend Per Share $0.19 per share Common stock dividend paid by Encompass Health on July 15, 2026

Closing Price on Payment Date $109.88 Share closing price used to calculate dividend-equivalent RSUs on July 15, 2026

Key Terms

restricted stock units, dividend record date, closing price, non-employee director

4 terms

restricted stock units financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend record date financial

"number of the RSUs in each director's account on the associated dividend record date"

closing price financial

"divided by (b) the closing price on the dividend payment date"

non-employee director financial

"RSUs are credited to each non-employee director's account in connection with dividend payments"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:18 PM Accepted by SEC EDGAR 07/16/2026 - 04:18 PM

FAQ

What insider transaction did Encompass Health (EHC) report for Nancy M. Schlichting?

Encompass Health reported that director Nancy M. Schlichting received an automatic award of 40 restricted stock units. The RSUs are tied to Encompass Health common stock and were credited in connection with a common stock dividend payment on July 15, 2026.

How many Encompass Health (EHC) shares or units does Nancy M. Schlichting hold after this Form 4?

After the reported award, Nancy M. Schlichting’s directly reported holdings total 22,972 shares. This figure reflects her position immediately following the 40-unit dividend-equivalent restricted stock award credited on July 15, 2026.

What triggered the 40 restricted stock units awarded to the Encompass Health (EHC) director?

The 40 RSUs were credited under existing restricted stock unit award agreements in connection with Encompass Health’s common stock dividend. On July 15, 2026, the company paid a $0.19 per-share dividend, which generated these dividend-equivalent units.

How were the Encompass Health (EHC) dividend-equivalent RSUs for Nancy M. Schlichting calculated?

The number of RSUs credited equals existing RSUs on the dividend record date multiplied by the $0.19 per-share dividend, divided by the $109.88 closing price on the July 15, 2026 dividend payment date, resulting in an award of 40 RSUs.

Was Nancy M. Schlichting’s Encompass Health (EHC) Form 4 a market purchase or sale?

No market purchase or sale occurred. The Form 4 reports an acquisition by grant/award of 40 restricted stock units. This is a compensation-related, dividend-equivalent award rather than an open-market buy or sell transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHLICHTING NANCY M

(Last)

(First)

(Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM

ALABAMA

35242

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Encompass Health Common Stock	07/15/2026		A		40⁽¹⁾	A	$0	22,972	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Nancy M. Schlichting	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR